SP-RASP and HoLEP have similar Outcomes for Prostatic Adenomas
In a recent study, Diego Aguilar Palacios and team assessed the perioperative outcomes of two minimally invasive surgical techniques for managing large prostatic adenomas: transvesical single-port robotic simple prostatectomy (SP-RASP) and holmium laser enucleation of the prostate (HoLEP) and found that both SP-RASP and HoLEP exhibit comparable favorable perioperative outcomes in the management of large prostatic adenomas. The findings were published in Urology Journal.
The study, conducted through a retrospective review of patients from 2019 to 2022, aimed to determine the advantages and disadvantages of each procedure for treating benign prostatic hyperplasia (BPH). They included a total of 50 patients who underwent SP-RASP and 90 patients who underwent HoLEP. All patients had preoperative prostatic volumes (PPV) greater than 80cm3. To estimate the percent of prostate adenoma removed (%PAR), researchers used the specimen weight normalized by the PPV. Univariate analysis was performed using Chi-square, Fisher’s exact, and Wilcoxon rank-sum tests, and a subgroup analysis with 1:1 matching for PPV was also conducted.
The findings revealed that the median PPV for SP-RASP was significantly higher than that of HoLEP (169cm3 vs. 129cm3, p<0.01). However, there was no significant difference in the median %PAR between the two techniques (57% for SP-RASP vs. 51% for HoLEP, p=0.10). Additionally, the overall rate of complications was similar in both groups, with 12% of HoLEP patients and 10% of SP-RASP patients experiencing complications (p=0.51).
One notable disparity was observed regarding same-day discharge rates, with 48% of SP-RASP patients discharged on the same day of the surgery compared to only 8% of HoLEP patients (p<0.01). The duration of foley catheter usage was also longer in SP-RASP patients, lasting six days on average, while HoLEP patients used the catheter for only one day (p<0.01). However, the success rate of the trial of void at the first attempt was similar in both groups, exceeding 94% (p=0.68).
Transient de-novo incontinence, although reported in both groups, occurred more frequently in HoLEP patients (28%) compared to SP-RASP patients (5%) (p<0.01). However, there were no significant differences in voiding parameters at the latest follow-up.
Source:
Palacios, D. A., Kaouk, J., Zeinab, M. A., Ferguson, E. L., Abramczyk, E., Wright, H. C., Pramod, N., & De, S. (2023). Holmium Laser Enucleation of the Prostate Versus Transvesical Single-Port Robotic Simple Prostatectomy for Large Prostatic Glands. In Urology. Elsevier BV. https://doi.org/10.1016/j.urology.2023.07.020
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.